S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Is AI Energy Really 4 Million Times More Powerful Than Oil? (Surprising Answer) (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
The #1 Crypto for 2024 (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
Secret Bull Market Starts in This Unusual Sector (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Is AI Energy Really 4 Million Times More Powerful Than Oil? (Surprising Answer) (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
The #1 Crypto for 2024 (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
Secret Bull Market Starts in This Unusual Sector (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Is AI Energy Really 4 Million Times More Powerful Than Oil? (Surprising Answer) (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
The #1 Crypto for 2024 (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
Secret Bull Market Starts in This Unusual Sector (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Is AI Energy Really 4 Million Times More Powerful Than Oil? (Surprising Answer) (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
The #1 Crypto for 2024 (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
Secret Bull Market Starts in This Unusual Sector (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
Free Trial
NASDAQ:AKU

Akumin (AKU) Stock Price, News & Analysis

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)
Free AKU Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
N/A
50-Day Range
$0.13
▼
$0.36
52-Week Range
N/A
Volume
8.54 million shs
Average Volume
1.38 million shs
Market Capitalization
$26.32 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$0.25
Stock AnalysisAnalyst ForecastsEarningsHeadlinesOwnershipSocial Media
AKU stock logo

About Akumin Stock (NASDAQ:AKU)

Akumin Inc. provides outpatient diagnostic imaging services in the United States. It operates in two segments, Radiology and Oncology. The company offers various medical imaging services, including magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other diagnostic and interventional radiology procedures through owned and/or operated imaging locations. It provides outpatient radiology, and oncology services and solutions to hospitals and health systems across 48 states. Akumin Inc. was founded in 2015 and is headquartered in Plantation, Florida.

AKU Stock News Headlines

February 21, 2024 | finance.yahoo.com
AKUMIN ANNOUNCES PARTNERSHIP WITH NORTHERN NEVADA SIERRA MEDICAL CENTER FOR RADIATION ONCOLOGY SERVICES
February 6, 2024 | finance.yahoo.com
Akumin Inc. Completes Deleveraging Transaction, Becomes a Private Company Wholly-Owned by Stonepeak
April 19, 2024 | Behind the Markets (Ad)
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
January 11, 2024 | fxstreet.com
2023 corporate bankruptcies topped pandemic year numbers
January 10, 2024 | msn.com
FACTBOX-US corporate bankruptcies hit 13-year peak in 2023
December 13, 2023 | theglobeandmail.com
Akumin: Top 10 Undervalued Healthcare Sector Stocks on TSX (AKU)
December 12, 2023 | ca.finance.yahoo.com
AKUMIN ANNOUNCES THIRD QUARTER 2023 RESULTS
November 2, 2023 | finance.yahoo.com
Akumin Inc. Provides Update on Trading on the Toronto Stock Exchange and Stockholder Information
April 19, 2024 | Behind the Markets (Ad)
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
October 25, 2023 | msn.com
Florida-based radiology provider Akumin Imaging files for bankruptcy amid 'ransomware incident'
October 23, 2023 | markets.businessinsider.com
Why EngageSmart Shares Are Trading Higher By Around 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session
October 23, 2023 | bizjournals.com
Multimillion-dollar public health care company to become privately held firm amid bankruptcy
October 23, 2023 | markets.businessinsider.com
Nasdaq Turns Higher; Akumin Shares Jump
October 23, 2023 | morningstar.com
North American Morning Briefing: 10-Year Treasury Yield Hits 5%
October 23, 2023 | markets.businessinsider.com
Why Is Troika Media (TRKA) Stock Down 20% Today?
October 23, 2023 | msn.com
Why Is Akumin (AKU) Stock Up 51% Today?
October 21, 2023 | marketwatch.com
Akumin Shares Rise 41% on Deal to Go Private
October 21, 2023 | msn.com
Akumin stock soars over 40% after company reaches agreement to go private
October 20, 2023 | marketwatch.com
Stocks to Watch: Great Ajax, Akumin, BioMarin Pharmaceutical
October 18, 2023 | news.yahoo.com
Medical provider Akumin turning away patients after apparent cyberattack
October 16, 2023 | marketwatch.com
Akumin Service Disrupted By Cyberattack
October 11, 2023 | msn.com
The largest cyberattack of its kind recently happened. Here’s how.
September 14, 2023 | ca.finance.yahoo.com
Akumin Inc. (AKU) Interactive Stock Chart - Yahoo Finance
August 10, 2023 | finanznachrichten.de
Akumin Inc.: Akumin Announces Second Quarter 2023 Results, Revised FY23 Financial Outlook and Establishment of Special Committee
August 7, 2023 | finance.yahoo.com
15 Worst Performing Tech Stocks in 2023
August 2, 2023 | theglobeandmail.com
Closing Bell: Akumin Inc down on Tuesday (AKU)
June 19, 2023 | benzinga.com
Bragar Eagel & Squire, P.C. Is Investigating Integra, Chinook, Phathom, and Akumin and Encourages Investors to Contact the Firm
See More Headlines
Receive AKU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Akumin and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
12/13/2021
Today
4/19/2024
Fiscal Year End
12/31/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical laboratories
Sub-Industry
N/A
Current Symbol
NASDAQ:AKU
CUSIP
N/A
CIK
1776197
Web
www.akumin.com
Phone
(844) 730-0050
Fax
N/A
Employees
3,631
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$0.25
High Stock Price Target
$0.25
Low Stock Price Target
$0.25
Consensus Rating
Reduce
Rating Score (0-4)
1.50
Research Coverage
2 Analysts

Profitability

EPS (Most Recent Fiscal Year)
($2.52)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-156,760,000.00
Net Margins
-30.56%
Pretax Margin
-28.78%
Return on Equity
-167.86%
Return on Assets
-7.81%

Debt

Debt-to-Equity Ratio
17.02
Current Ratio
0.99
Quick Ratio
0.99

Sales & Book Value

Annual Sales
$749.63 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.24 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
91,170,000
Free Float
72,473,000
Market Cap
$26.32 million
Optionable
Not Optionable
Beta
-0.72
Beginner's Guide to Pot Stock Investing Cover
Beginner's Guide to Pot Stock Investing

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

  • Mr. Riadh Zine-El-Abidine (Age 51)
    Chairman & CEO
    Comp: $1.78M
  • Mr. David Krestchmer (Age 65)
    Chief Financial Officer
    Comp: $580.51k
  • Mr. Krishna Kumar Ananthasubramanian
    Pres & COO
  • Mr. Paul Nelis (Age 55)
    Chief Information Officer
  • Darren Speed
    Chief Compliance Officer
  • Ms. Tracy Wiese (Age 54)
    Chief Strategy & Marketing Officer
  • Ms. Holly Huso (Age 58)
    Enterprise Sales Officer
  • Ms. Laurie R. Miller (Age 56)
    Chief HR Officer
  • Mr. Mohammad Saleem
    Sr. VP of Financial Reporting
  • Mr. Christopher Fitzgerald
    Chief Revenue Officer

Key Competitors

View All Competitors

AKU Stock Analysis - Frequently Asked Questions

Should I buy or sell Akumin stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Akumin in the last twelve months. There are currently 1 sell rating and 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "reduce" AKU shares.
View AKU analyst ratings or view top-rated stocks.

What is Akumin's stock price target for 2024?

2 Wall Street research analysts have issued 12 month price targets for Akumin's shares. Their AKU share price targets range from $0.25 to $0.25. On average, they anticipate the company's stock price to reach $0.25 in the next twelve months.
View analysts price targets for AKU or view top-rated stocks among Wall Street analysts.

How were Akumin's earnings last quarter?

Akumin Inc. (NASDAQ:AKU) issued its quarterly earnings data on Monday, December, 13th. The company reported ($0.02) earnings per share for the quarter, topping the consensus estimate of ($0.43) by $0.41. The business earned $108.18 million during the quarter, compared to analysts' expectations of $109.25 million. Akumin had a negative trailing twelve-month return on equity of 167.86% and a negative net margin of 30.56%.

This page (NASDAQ:AKU) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Tiny Biotech Stock Wins $75 Billion Patent
Behind the Markets
Biden’s $374B Giveaway Into This Sector
DTI
SHOCKING Crypto Leak…
Crypto 101 Media
He Is Giving Away Bitcoin
Crypto Swap Profits
The #1 Crypto for 2024
InvestorPlace
How Biden has already won 2024
Porter & Company
Top 5 AI Stocks to Buy for 2024
Market Moving Trends
Urgent alert: open this for a huge profit potential
Timothy Sykes